BR9205827A - Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior - Google Patents

Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior

Info

Publication number
BR9205827A
BR9205827A BR9205827A BR9205827A BR9205827A BR 9205827 A BR9205827 A BR 9205827A BR 9205827 A BR9205827 A BR 9205827A BR 9205827 A BR9205827 A BR 9205827A BR 9205827 A BR9205827 A BR 9205827A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
gastrointestinal tract
upper gastrointestinal
treating disorders
ingestible pharmaceutical
Prior art date
Application number
BR9205827A
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9205827A publication Critical patent/BR9205827A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9205827A 1991-04-04 1992-03-13 Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior BR9205827A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04
PCT/US1992/001981 WO1992017164A1 (en) 1991-04-04 1992-03-13 Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress

Publications (1)

Publication Number Publication Date
BR9205827A true BR9205827A (pt) 1994-06-28

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9205827A BR9205827A (pt) 1991-04-04 1992-03-13 Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior

Country Status (16)

Country Link
EP (1) EP0578768B1 (pt)
JP (1) JPH06506682A (pt)
KR (1) KR100238565B1 (pt)
AT (1) ATE128351T1 (pt)
AU (1) AU665349B2 (pt)
BR (1) BR9205827A (pt)
CA (1) CA2106215C (pt)
CZ (1) CZ282105B6 (pt)
DE (1) DE69205158T2 (pt)
DK (1) DK0578768T3 (pt)
ES (1) ES2077417T3 (pt)
GR (1) GR3017580T3 (pt)
HU (1) HU213203B (pt)
RU (1) RU2126249C1 (pt)
SK (1) SK121293A3 (pt)
WO (1) WO1992017164A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
JPH08509725A (ja) * 1993-04-30 1996-10-15 ザ、プロクター、エンド、ギャンブル、カンパニー コートされた医薬組成物
DK0698393T3 (da) * 1993-05-19 2002-08-05 Hisamitsu Pharmaceutical Co 3-/-menthoxypropan-1,2-diol som solubiliseringsmiddel og præparat til udvortes brug, der indeholder samme
AU7565594A (en) * 1993-08-17 1995-03-14 Applied Analytical Industries, Inc. Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
AU8084594A (en) * 1993-10-28 1995-05-22 Procter & Gamble Company, The Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
CA2184361C (en) * 1994-03-24 2000-12-05 Francis Bernard Chapura Solid dose forms containing bismuth
PE33896A1 (es) * 1994-07-20 1996-09-02 American Home Prod Composicion farmaceutica para el tratamiento del malestar gastrico
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp 3−l−メントキシプロパン−1、2−ジオ−ル

Also Published As

Publication number Publication date
WO1992017164A1 (en) 1992-10-15
HU9302970D0 (en) 1994-01-28
CZ282105B6 (cs) 1997-05-14
DE69205158T2 (de) 1996-04-18
GR3017580T3 (en) 1995-12-31
JPH06506682A (ja) 1994-07-28
RU2126249C1 (ru) 1999-02-20
HUT65881A (en) 1994-07-28
KR100238565B1 (ko) 2000-02-01
CA2106215A1 (en) 1992-10-05
AU665349B2 (en) 1996-01-04
EP0578768B1 (en) 1995-09-27
HU213203B (en) 1997-03-28
CA2106215C (en) 1997-05-27
CZ226093A3 (en) 1994-04-13
SK121293A3 (en) 1994-07-06
DK0578768T3 (da) 1996-02-05
AU1761492A (en) 1992-11-02
EP0578768A1 (en) 1994-01-19
ES2077417T3 (es) 1995-11-16
ATE128351T1 (de) 1995-10-15
DE69205158D1 (de) 1995-11-02

Similar Documents

Publication Publication Date Title
BR9205827A (pt) Composições farmacêuticas ingeriveis para tratamento de distúrbios do trato gastrintestinal superior
CY2020003I2 (el) Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις για την θεραπευτικη αγωγη της παθολογιας του crohn
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
NO902280D0 (no) Ny poroes farmasoeytisk form og fremstilling derav.
DE122007000022I2 (de) Pharmazeutische zusammensetzungen, welche ausgewählte lanthancarbonathydrate enthalten
HK1003978A1 (en) Composition for the treatment of schizophrenia
FR2719999B1 (fr) Composition pharmaceutique à base de gomme de guar et d'un antiacide neutralisant, à laquelle peut être ajoutée une série de principes actifs thérapeutiques.
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
DK0589893T3 (da) Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori
IT1229568B (it) Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
ES2107280T3 (es) Sales de nefazodona que tienen velocidades de disolucion mejoradas.
NO976048D0 (no) Farmasöytiske og diett formuleringer for profylakse og behandling av mave- og tarmforstyrrelser
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
ATA186692A (de) Pharmazeutische zusammensetzung
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
KR890009400A (ko) 다이클로닌 Hcl및 페놀을 함유하는 약제학적 조성물
HUP0001104A2 (hu) Ibuprofent és domperidont tartalmazó készítmények migrén kezelésére
SE0001916D0 (sv) Novel formulation
NO920143L (no) Substituerte 2-imidazoliner og fremstilling og anvendelsederav
BR0002772A (pt) Uso de ligantes melatoninérgicos na obtenção de composições farmacêuticas pretendidas para a prevenção ou o tratamento de patologias do sistema gastrintestinal
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
DE69132392D1 (de) Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
JPS57128627A (en) Analgesic and antiphlogistic composition
ITMI20010971A0 (it) Formulazioni farmaceutiche e/o dietetiche contenenti colostro e uso del colostro per il trattamento dell'acne

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
CKFC Appeal: appeal against refusal